External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting

NCT07053098 | Recruiting

• 1 other identifier: 1R34AA032051-01
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

This project will pilot test an implementation facilitation intervention to increase prescribing of medications for alcohol use disorder (MAUD) in patients with major mental illness and alcohol use disorder in three psychiatry treatment clinics.

Conditions

Alcohol-Related Disorders; Psychiatric Disorder

Outcome Measures

Primary Outcomes (1)

• Prescribing medications for alcohol use disorder

  Change in the proportion of eligible patients prescribed a medication for alcohol use disorder in the clinic

  6 months after the end of implementation facilitation

Study Arms (1)

Implementation Facilitation

EXPERIMENTAL

This Implementation Facilitation Intervention will include external facilitation, staff training, patient education, audit and feedback, and care coordination.

Other: Implementation Facilitation

Interventions

Implementation Facilitation OTHER

Implementation facilitation is a multi-faceted process of enabling and supporting the adoption and integration of best practices into routine clinical care. It involves collaboration to understand a setting's challenges and barriers and working together to identify the best activities to address them. IF will incorporate External Facilitation, a problem-solving implementation strategy that builds supportive interpersonal relationships between an External Facilitator who is outside of the clinic who works with clinics and their identified internal champions to learn their unique barriers to implementation, use strategies to address these barriers, and plan for sustainability by integrating the practice into routine processes and workflows. Other implementation activities that will be used IF include staff training, patient education, audit and feedback, and care coordination.

Implementation Facilitation

Eligibility Criteria

• Age: 18 Years - 90 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• For prescribers: working as a prescriber, non-prescribing clinician, or administrator at one of the three participating clinics.
• For patients: has major mental illness (major depressive disorders, bipolar disorder, schizophrenia spectrum disorders, other psychotic disorders; posttraumatic stress disorder)
• For patients: has Alcohol Use Disorder and is being treated in one of the three participating clinics.

You may not qualify if:

• For all: age is less than 18 years old
• For all: not able to complete informed consent

Sponsors & Collaborators

• University of Maryland, Baltimore: lead

Study Sites (1)

University of Maryland Baltimore

Baltimore, Maryland, 21201, United States

RECRUITING

MeSH Terms

Conditions

Alcohol-Related Disorders; Mental Disorders

Condition Hierarchy (Ancestors)

Substance-Related Disorders; Chemically-Induced Disorders

Study Officials

• Melanie Bennett

  University of Maryland, Baltimore

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Melanie Bennett, PhD

CONTACT

410-706-2490; mbennett@som.umaryland.edu

Brian Brandler

CONTACT

410-706-2490; bbrandler@som.umaryland.edu

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: June 30, 2025
• First Posted: July 8, 2025
• Study Start: March 18, 2025
• Primary Completion (Estimated): May 31, 2027
• Study Completion (Estimated): May 31, 2027
• Last Updated: July 8, 2025

Record last verified: 2025-06

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)